Clinical trial
A Multicenter Randomized Exploratory Clinical Trial to Evaluate the Effect of Bone Metabolism and the Efficacy of Evogliptin and Dapagliflozin for Blood Sugar in the Menopause Female Patients With Osteopenia and Type 2 Diabetes
NCT04706637 is registered in ClinicalTrials.gov with Kyung Hee University Hospital at Gangdong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Randomized Exploratory Clinical Trial to Evaluate the Effect of Bone Metabolism and the Efficacy of Evogliptin and Dapagliflozin for Blood Sugar in the Menopause Female Patients With Osteopenia and Type 2 Diabetes
- Lead sponsor
- Kyung Hee University Hospital at Gangdong
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- February 1, 2021
- Completion date
- January 31, 2023
- Enrollment
- 120 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.